Q1 2021 Holdings
Filed 2021-05-18 | 91 holdings | $21.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $8.5M | 336,737 | 39.9% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $3.8M | 321,879 | 18.0% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $2.4M | 18,694 | 11.3% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $1.7M | 25,071 | 7.8% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $1.5M | 100,000 | 6.9% |
| Biogen Inc(BIIB) | COM | 09062X103 | $1.4M | 5,000 | 6.6% |
| Unum Therapeutics Inc(COGT) | COM | 19240Q201 | $1.1M | 120,000 | 5.0% |
| Actinium Pharmaceuticals Inc(ATNM) | COM | 00507W206 | $350.0K | 45,910 | 1.6% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $298.0K | 45,000 | 1.4% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $146.0K | 6,000 | 0.7% |
| Curis Inc(CRISEUR) | COM NEW | 231269200 | $7.1K | 628,793 | 0.0% |
| Vericel Corp(VCEL) | COM | 92346J108 | $6.8K | 122,125 | 0.0% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $6.5K | 190,810 | 0.0% |
| Amryt Pharma PLC | SPONSORED ADS | 03217L106 | $6.0K | 429,863 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $5.9K | 729,364 | 0.0% |
| Research Alliance Corp II | COM CL A | 760873109 | $5.1K | 500,000 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $5.1K | 200,000 | 0.0% |
| Merus N V | COM | N5749R100 | $5.1K | 244,713 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $4.5K | 48,476 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $4.4K | 130,117 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $4.4K | 104,945 | 0.0% |
| Medicus Sciences Acquisition | UNIT 99/99/9999 | G5960S116 | $4.0K | 406,791 | 0.0% |
| Affimed N V | COM | N01045108 | $4.0K | 502,330 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $3.8K | 60,000 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $3.6K | 350,000 | 0.0% |
| Renalytix AI PLC | ADS | 75973T101 | $3.5K | 134,555 | 0.0% |
| Tcr2 Therapeutics Inc | COM | 87808K106 | $3.4K | 155,145 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $3.4K | 50,089 | 0.0% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $3.2K | 60,000 | 0.0% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $3.0K | 300,000 | 0.0% |
| Verastem Inc | COM | 92337C104 | $3.0K | 1,197,489 | 0.0% |
| Salarius Pharmaceuticals Inc | COM NEW | 79400X107 | $2.9K | 1,992,181 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $2.9K | 55,974 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $2.8K | 191,945 | 0.0% |
| Biogen Inc(BIIB)Call | COM | 09062X103 | $2.8K | 10,000 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $2.5K | 522,589 | 0.0% |
| Helix Acquisition Corp | COM CL A | G4444C102 | $2.3K | 228,485 | 0.0% |
| Sierra Oncology Inc | COM NEW | 82640U404 | $2.3K | 134,681 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $2.3K | 80,000 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $2.1K | 73,451 | 0.0% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $2.1K | 100,000 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $1.8K | 36,221 | 0.0% |
| Oncorus Inc | COM | 68236R103 | $1.8K | 130,000 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $1.8K | 39,765 | 0.0% |
| Cyclacel Pharmaceuticals Inc | COM | 23254L603 | $1.8K | 250,000 | 0.0% |
| Evogene LTD(EVGN) | SHS | M4119S104 | $1.8K | 350,000 | 0.0% |
| Odonate Therapeutics Inc | COM | 676079106 | $1.7K | 500,000 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $1.6K | 7,500 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $1.6K | 16,741 | 0.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $1.6K | 10,192 | 0.0% |